AbbVie a new outperform at RBC Capital Markets on durable growth
RBC Capital Markets has initiated coverage of AbbVie (ABBV) at outperform saying the company has underperformed based on...
Tag: ABBV
AbbVie earmarks $380M to build two manufacturing facilities in Illinois
AbbVie (ABBV) will spend $380M to build two new active pharmaceutical ingredient plants at its current grounds in North...
AbbVie wins FDA approval for Venclexta-acalabrutinib combo in first-line chronic lymphocytic leukemia
AbbVie (ABBV) said Friday that the U.S. Food and Drug Administration has approved a supplemental new drug application for...
China drug licensing deals surge nearly 10-fold in value since 2021
Drug licensing deals between Chinese companies and global pharmaceutical companies surged to a record $137.7B last year,...
China drug licensing deals surge nearly 10-fold in value since 2021
Drug licensing deals between Chinese companies and global pharmaceutical companies surged to a record $137.7B last year,...
AbbVie declares $1.73 dividend
AbbVie (ABBV) declares $1.73/share quarterly dividend, in line with previous. Forward yield 3.04% Payable May 15; for...
AbbVie declares $1.73 dividend
AbbVie (ABBV) declares $1.73/share quarterly dividend, in line with previous. Forward yield 3.04% Payable May 15; for...
AbbVie files lawsuit over selection of Botox for Medicare price negotiations
AbbVie has sued the Department of Health and Human Services (HHS), challenging the agency’s decision to select its...
AbbVie forecasts 9.5% sales growth in 2026 amid blockbuster launches and pipeline momentum
Earnings Call Insights: AbbVie (ABBV) Q4 2025 Robert Michael, CEO & Chairman of the Board, reported "record net sales...
AbbVie nears five-month low as Humira drives Q4 beat, not Rinvoq
Shares of AbbVie (ABBV) lost ~7% on Wednesday after the Chicago-based pharma giant posted better-than-expected Q4 2025...